AstraZeneca Q2 profits up 22 pct
AstraZeneca PLC posted a 22 percent rise in second quarter net profit on Thursday as it also revealed that a key new drug – its blood thinner Brilinta – has been given a thumbs up by an advisory committee of the U.S. Food and Drug Administration.
Read more on Seattle Times
Related posts: